Cite

Copy

Tap on and choose 'Add to Home Screen' to create a shortcut app

Tap on and choose 'Add to Home Screen/Install App' to create a shortcut app

References for High-Grade Gliomas in Children

This page was last updated on August 19th, 2022

  1. Pollack IF: Brain tumors in children. N Engl J Med 331:1500-1507, 1994
  2. Tamber MS, Rutka JT: Pediatric supratentorial high-grade gliomas. Neurosurg Focus 14 (2):e1, 2003
  3. CBTRUS. Statistical Report: Primary Brain Tumors in the United States, 1998-2002. Hinsdale, IL: Central Brain Tumor Registry of the United States, 2005
  4. Broniscer A, Gajjar A: Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist 9:197-206, 2004
  5. Song KS, Phi JH, Cho BK, et al: Long-term outcomes in children with glioblastoma. J Neurosurg Pediatr 6:145-149, 2010
  6. Schlehofer B, Hettinger I, Ryan P, et al: Occupational risk factors for low grade and high grade glioma: results from an international case control study of adult brain tumours. Int J Cancer 113:116-125, 2005
  7. Kranzinger M, Jones N, Rittinger O, et al: Malignant glioma as a secondary malignant neoplasm after radiation therapy for craniopharyngioma: report of a case and review of reported cases. Onkologie 24:66-72, 2001
  8. Kleihues P, Burger PC, Rosenblum, et al: Anaplastic astrocytoma, in Louis DN OH, Wiestler OD, Cavenee WK (eds): World Health Organization Classification of Tumours of the Central Nervous System, ed 4. Lyon: International Agency for Research on Cancer, 2007, pp 30-32
  9. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3:255-268, 1993
  10. Kleihues P, Burger PC, Aldape, KD, et al: Glioblastoma, in Louis DN OH, Wiestler OD, Cavenee WK (eds): World Health Organization Classification of Tumours of the Central Nervous System, ed 4. Lyon: International Agency for Research on Cancer, 2007, pp 164-172
  11. Suri V, Das P, Pathak P, et al: Pediatric glioblastomas: a histopathological and molecular genetic study. Neuro Oncol 11:274-280, 2009
  12. Ohgaki H, Eibl RH, Schwab M, et al: Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinog 8:74-80, 1993
  13. Ichimura K, Schmidt EE, Miyakawa A, et al: Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades. Genes Chromosomes Cancer 22:9-15, 1998
  14. Dropcho EJ, Wisoff JH, Walker RW, et al: Supratentorial malignant gliomas in childhood: a review of fifty cases. Ann Neurol 22:355-364, 1987
  15. Howe FA, Opstad KS: 1H MR spectroscopy of brain tumours and masses. NMR Biomed 16:123-131, 2003
  16. Billingsley RL, Lang FF, Slopis JM, et al: Visual-spatial neglect in a child following sub-cortical tumor resection. Dev Med Child Neurol 44:191-199, 2002
  17. Sposto R, Ertel IJ, Jenkin RD, et al: The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neurooncol 7:165-177, 1989
  18. Finlay JL, Boyett JM, Yates AJ, et al: Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol 13:112-123, 1995
  19. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005
  20. Lashford LS, Thiesse P, Jouvet A, et al: Temozolomide in malignant gliomas of childhood: a United Kingdom Children’s Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol 20:4684-4691, 2002
  21. Cohen KJ, Pollack IF, Zhou T, et al: Temozolomide in the treatment of high-grade gliomas in children: a report from the Children’s Oncology Group. Neuro Oncol 13:317-323, 2011
  22. Massimino M, Gandola L, Luksch R, et al: Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma. Neuro Oncol 7:41-48, 2005
  23. Reddy AT, Wellons JC, 3rd: Pediatric high-grade gliomas. Cancer J 9:107-112, 2003
  24. Hodgson DC, Goumnerova LC, Loeffler JS, et al: Radiosurgery in the management of pediatric brain tumors. Int J Radiat Oncol Biol Phys 50:929-935, 2001
  25. Tarapore P, Banerjee A, Gupta N: Supratentorial high-grade gliomas, in Tonn J, Westphal, M, Rutka, JR (eds): Oncology of CNS Tumors, ed 2. Berlin Heidelberg: Springer-Verlag, 2010, pp 427-434
  26. Baumann GS, Wara WM, Larson DA, et al: Gamma knife radiosurgery in children. Pediatr Neurosurg 24:193-201, 1996
  27. Chow KH, Gottschalk S: Cellular immunotherapy for high-grade glioma. Immunotherapy 3:423-434, 2011
  28. Driggers L, Zhang JG, Newcomb EW, et al: Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper. J Neurooncol 97:159-169, 2010
  29. Allen JC: Complications of chemotherapy in patients with brain and spinal cord tumors. Pediatr Neurosurg 17:218-224, 1991
  30. Neervoort FW, Van Ouwerkerk WJR, Folkersman H, et Al: Surgical morbidity and mortality of pediatric brain tumors: a single center audit. Childs Nerv Syst. 26:1583–1592, 2010
  31. Gururangan S, Chi SN, Young Poussaint T, et al: Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study. J Clin Oncol 28:3069-3075, 2010
  32. Bobo RH, Laske DW, Akbasak A, et al: Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 91:2076-2080, 1994
  33. Ries LAG, Smith MA, Gurney JG, et al (eds): Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD, 1999
  34. MacDonald TJ, Arenson EB, Ater J, et al: Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children’s Cancer Group Study 9933. Cancer 104: 2862-2871, 2005
  35. Musial-Bright L, Fengler R, Henze G, et al: Carboplatin and ototoxicity: hearing loss among survivors of childhood medulloblastoma. Childs Nerv Syst 27:407-413, 2011
  36. Vauleon E, Avril T, Collet B, et al: Overview of cellular immunotherapy for patients with glioblastoma. Clin Dev Immunol 2010, Article ID 689171: 1-18
  37. Wisoff JH, Boyett JM, Berger MS, et al: Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children’s Cancer Group trial no. CCG-945. J Neurosurg 89:52-59, 1998
  38. Phuphanich S, Edwards MS, Levin VA, et al: Supratentorial malignant gliomas of childhood. Results of treatment with radiation therapy and chemotherapy. J Neurosurg 60:495-499, 1984

Your donations keep us going

The ISPN Guide is free to use, but we rely on donations to fund our ongoing work and to maintain more than a thousand pages of information created to disseminate the most up-to-date knowledge in the field of paediatric neurosurgery.

By making a donation to The ISPN Guide you are also indirectly helping the many thousands of children around the world whose treatment depends on well-informed surgeons.

Please consider making a donation today.

Use the app

The ISPN Guide can be used as a standalone app, both on mobile devices and desktop computers. It’s quick and easy to use.

Fully featured

Free registration grants you full access to The Guide and host of featured designed to help further your own education.

Stay updated

The ISPN Guide continues to expand both in breadth and depth. Join our mailing list to stay up-to-date with our progress.